Is It Possible to Regenerate the Underactive Detrusor? Part 1 Molecular and Stem Cell Therapies Targeting the Urinary Bladder and Neural Axis ICI‐RS 2024
S Sinha, F Cruz, EM Cuenca… - Neurourology and …, 2024 - Wiley Online Library
Introduction Detrusor muscle weakness is commonly noted on urodynamics in patients with
refractory voiding difficulty. No approved therapies have been proven to augment the …
refractory voiding difficulty. No approved therapies have been proven to augment the …
Is it Possible to Regenerate the Underactive Detrusor? Part 2 Electrical Stimulation Therapies, Treatment of Bladder Outlet Obstruction, Constipation, and Pelvic Floor …
Introduction Detrusor muscle weakness is commonly noted on urodynamics in patients with
refractory voiding difficulty. No clinical therapy has been proven to augment the strength of a …
refractory voiding difficulty. No clinical therapy has been proven to augment the strength of a …
Investigation on clinical risk factors of bladder lesion by machine learning based interpretable model
Y Wang, J Li, Y Song, H Wei, Z Yan, S Chen… - Scientific Reports, 2024 - nature.com
Bladder lesion commonly occurs in patients with benign prostatic hyperplasia (BPH), and
the routine screening of bladder lesion is vital for its timely detection and treatment, in which …
the routine screening of bladder lesion is vital for its timely detection and treatment, in which …
[HTML][HTML] Impact of Urethral Sphincter Electrophysiology on Botulinum Toxin A Treatment in Women with Non-Neurogenic Dysfunctional Voiding
TL Chang, YH Jiang, HC Kuo - Biomedicines, 2024 - mdpi.com
Dysfunctional voiding (DV) is an abnormal urethral sphincter activity during voiding in
neurologically normal individuals. Urethral sphincter botulinum toxin A (BoNT-A) injection …
neurologically normal individuals. Urethral sphincter botulinum toxin A (BoNT-A) injection …